Skip to main content
Premium Trial:

Request an Annual Quote

Bruker, Chungnam National University Partner on Glycan Analysis

NEW YORK (GenomeWeb News) – Bruker and Chungnam National University in South Korea announced today a collaboration to develop MALDI-TOF-based methodologies for the analysis of glycans.

The deal between Bruker and the Graduate School of Analytical Science and Technology at the university will be targeted mainly at creating methods and software applications in the development and quality control of biologics, such as therapeutic antibodies, they said.

The partnership will also serve as an Asia Glycomics Reference Site and provide support to the wider Asian Glycomics community, they added. The work is expected to "create a better understanding of the function of glycans in biomolecules and their key role in many biological processes."

Financial and other terms of the deal were not disclosed.

The research will be led by Hyun Joo An, a professor at the university, and Detlev Suckau at Bruker.

"The potential we see, particularly for the biosimilar industry, indicates that glycan research will continue to increase in importance, particularly as workflows develop to unravel its complexities," An said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more